Logo image of MHUA

MEIHUA INTERNATIONAL MEDICAL (MHUA) Stock Fundamental Analysis

NASDAQ:MHUA - Nasdaq - KYG5966G1082 - Common Stock - Currency: USD

0.4551  -0.01 (-2.67%)

After market: 0.4551 0 (0%)

Fundamental Rating

5

Taking everything into account, MHUA scores 5 out of 10 in our fundamental rating. MHUA was compared to 188 industry peers in the Health Care Equipment & Supplies industry. While MHUA has a great health rating, its profitability is only average at the moment. MHUA has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

MHUA had positive earnings in the past year.
In the past year MHUA had a positive cash flow from operations.
Each year in the past 5 years MHUA has been profitable.
The reported operating cash flow has been mixed in the past 5 years: MHUA reported negative operating cash flow in multiple years.
MHUA Yearly Net Income VS EBIT VS OCF VS FCFMHUA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 10M -10M 20M

1.2 Ratios

MHUA's Return On Assets of 9.12% is amongst the best of the industry. MHUA outperforms 92.02% of its industry peers.
Looking at the Return On Equity, with a value of 10.93%, MHUA belongs to the top of the industry, outperforming 86.70% of the companies in the same industry.
MHUA has a better Return On Invested Capital (8.53%) than 90.43% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for MHUA is in line with the industry average of 7.71%.
Industry RankSector Rank
ROA 9.12%
ROE 10.93%
ROIC 8.53%
ROA(3y)8.61%
ROA(5y)12.96%
ROE(3y)10.61%
ROE(5y)16.01%
ROIC(3y)8.98%
ROIC(5y)13.13%
MHUA Yearly ROA, ROE, ROICMHUA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 10 20 30

1.3 Margins

With an excellent Profit Margin value of 11.47%, MHUA belongs to the best of the industry, outperforming 87.77% of the companies in the same industry.
In the last couple of years the Profit Margin of MHUA has declined.
MHUA's Operating Margin of 14.44% is amongst the best of the industry. MHUA outperforms 84.04% of its industry peers.
MHUA's Operating Margin has declined in the last couple of years.
The Gross Margin of MHUA (33.97%) is worse than 71.81% of its industry peers.
In the last couple of years the Gross Margin of MHUA has declined.
Industry RankSector Rank
OM 14.44%
PM (TTM) 11.47%
GM 33.97%
OM growth 3Y-16.94%
OM growth 5Y-9.84%
PM growth 3Y-17.5%
PM growth 5Y-10.18%
GM growth 3Y-6.44%
GM growth 5Y-4.15%
MHUA Yearly Profit, Operating, Gross MarginsMHUA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 10 20 30 40

More info and screens

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so MHUA is still creating some value.
MHUA has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, MHUA has more shares outstanding
MHUA has a worse debt/assets ratio than last year.
MHUA Yearly Shares OutstandingMHUA Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M
MHUA Yearly Total Debt VS Total AssetsMHUA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 50M 100M 150M

2.2 Solvency

MHUA has an Altman-Z score of 3.13. This indicates that MHUA is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 3.13, MHUA is doing good in the industry, outperforming 71.28% of the companies in the same industry.
The Debt to FCF ratio of MHUA is 1.37, which is an excellent value as it means it would take MHUA, only 1.37 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 1.37, MHUA belongs to the best of the industry, outperforming 90.43% of the companies in the same industry.
A Debt/Equity ratio of 0.08 indicates that MHUA is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.08, MHUA is in the better half of the industry, outperforming 61.70% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 1.37
Altman-Z 3.13
ROIC/WACC1.46
WACC5.85%
MHUA Yearly LT Debt VS Equity VS FCFMHUA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 50M 100M

2.3 Liquidity

A Current Ratio of 4.78 indicates that MHUA has no problem at all paying its short term obligations.
With a decent Current ratio value of 4.78, MHUA is doing good in the industry, outperforming 70.74% of the companies in the same industry.
A Quick Ratio of 4.74 indicates that MHUA has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 4.74, MHUA is in the better half of the industry, outperforming 76.60% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.78
Quick Ratio 4.74
MHUA Yearly Current Assets VS Current LiabilitesMHUA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

More info and screens

1

3. Growth

3.1 Past

MHUA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 13.80%, which is quite good.
MHUA shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -8.81% yearly.
The Revenue has decreased by -6.00% in the past year.
The Revenue has been growing slightly by 5.11% on average over the past years.
EPS 1Y (TTM)13.8%
EPS 3Y-20.04%
EPS 5Y-8.81%
EPS Q2Q%-47.93%
Revenue 1Y (TTM)-6%
Revenue growth 3Y2.91%
Revenue growth 5Y5.11%
Sales Q2Q%-5.91%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MHUA Yearly Revenue VS EstimatesMHUA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 0.71, the valuation of MHUA can be described as very cheap.
Based on the Price/Earnings ratio, MHUA is valued cheaply inside the industry as 99.47% of the companies are valued more expensively.
MHUA is valuated cheaply when we compare the Price/Earnings ratio to 26.25, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 0.71
Fwd PE N/A
MHUA Price Earnings VS Forward Price EarningsMHUA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

MHUA's Price/Free Cash Flow ratio is rather cheap when compared to the industry. MHUA is cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 1.69
EV/EBITDA -0.17
MHUA Per share dataMHUA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

MHUA has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

MHUA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MEIHUA INTERNATIONAL MEDICAL

NASDAQ:MHUA (5/30/2025, 8:16:27 PM)

After market: 0.4551 0 (0%)

0.4551

-0.01 (-2.67%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-29 2022-11-29/bmo
Earnings (Next)N/A N/A
Inst Owners0.8%
Inst Owner Change32.51%
Ins Owners49.95%
Ins Owner ChangeN/A
Market Cap14.52M
AnalystsN/A
Price TargetN/A
Short Float %1.77%
Short Ratio1.3
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 0.71
Fwd PE N/A
P/S 0.1
P/FCF 1.69
P/OCF 1.67
P/B 0.1
P/tB 0.1
EV/EBITDA -0.17
EPS(TTM)0.64
EY140.63%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.27
FCFY59.2%
OCF(TTM)0.27
OCFY60.01%
SpS4.47
BVpS4.69
TBVpS4.67
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 9.12%
ROE 10.93%
ROCE 13.75%
ROIC 8.53%
ROICexc 9.64%
ROICexgc 9.67%
OM 14.44%
PM (TTM) 11.47%
GM 33.97%
FCFM 6.03%
ROA(3y)8.61%
ROA(5y)12.96%
ROE(3y)10.61%
ROE(5y)16.01%
ROIC(3y)8.98%
ROIC(5y)13.13%
ROICexc(3y)10.01%
ROICexc(5y)15.52%
ROICexgc(3y)10.12%
ROICexgc(5y)15.69%
ROCE(3y)14.05%
ROCE(5y)20.48%
ROICexcg growth 3Y-27.88%
ROICexcg growth 5Y-29.21%
ROICexc growth 3Y-28.39%
ROICexc growth 5Y-29.35%
OM growth 3Y-16.94%
OM growth 5Y-9.84%
PM growth 3Y-17.5%
PM growth 5Y-10.18%
GM growth 3Y-6.44%
GM growth 5Y-4.15%
F-Score4
Asset Turnover0.8
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 1.37
Debt/EBITDA 0.56
Cap/Depr 24.8%
Cap/Sales 0.08%
Interest Coverage 86.2
Cash Conversion 41.41%
Profit Quality 52.59%
Current Ratio 4.78
Quick Ratio 4.74
Altman-Z 3.13
F-Score4
WACC5.85%
ROIC/WACC1.46
Cap/Depr(3y)537.79%
Cap/Depr(5y)817.43%
Cap/Sales(3y)2.75%
Cap/Sales(5y)4.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)13.8%
EPS 3Y-20.04%
EPS 5Y-8.81%
EPS Q2Q%-47.93%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-6%
Revenue growth 3Y2.91%
Revenue growth 5Y5.11%
Sales Q2Q%-5.91%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y3.36%
EBIT growth 3Y-14.53%
EBIT growth 5Y-5.23%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y79.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y124.85%
OCF growth 3Y-24.7%
OCF growth 5Y-28.07%